These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 31040845)

  • 1. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
    Pérez-Sánchez L; Patiño-Trives AM; Aguirre-Zamorano MÁ; Luque-Tévar M; Ábalos-Aguilera MC; Arias-de la Rosa I; Seguí P; Velasco-Gimena F; Barbarroja N; Escudero-Contreras A; Collantes-Estévez E; Pérez-Sánchez C; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):865-877. PubMed ID: 33356391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS
    Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome's genetic and epigenetic aspects.
    Iuliano A; Galeazzi M; Sebastiani GD
    Autoimmun Rev; 2019 Sep; 18(9):102352. PubMed ID: 31323355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.
    Pérez-Sánchez C; Aguirre MA; Ruiz-Limón P; Barbarroja N; Jiménez-Gómez Y; de la Rosa IA; Rodriguez-Ariza A; Collantes-Estévez E; Segui P; Velasco F; Cuadrado MJ; Teruel R; González-Conejero R; Martínez C; López-Pedrera Ch
    Sci Rep; 2016 Aug; 6():31375. PubMed ID: 27502756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.
    Pérez-Sánchez C; Arias-de la Rosa I; Aguirre MÁ; Luque-Tévar M; Ruiz-Limón P; Barbarroja N; Jiménez-Gómez Y; Ábalos-Aguilera MC; Collantes-Estévez E; Segui P; Velasco F; Herranz MT; Lozano-Herrero J; Hernandez-Vidal MJ; Martínez C; González-Conejero R; Radin M; Sciascia S; Cecchi I; Cuadrado MJ; López-Pedrera C
    Haematologica; 2018 May; 103(5):908-918. PubMed ID: 29545345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
    Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
    Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome.
    Domenico Sebastiani G; Minisola G; Galeazzi M
    Autoimmun Rev; 2003 Oct; 2(6):387-94. PubMed ID: 14550881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in genomics and epigenetics in antiphospholipid syndrome.
    López-Pedrera C; Cerdó T; Jury EC; Muñoz-Barrera L; Escudero-Contreras A; Aguirre MA; Pérez-Sánchez C
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI14-SI23. PubMed ID: 38320594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS.
    Chaturvedi S; Braunstein EM; Yuan X; Yu J; Alexander A; Chen H; Gavriilaki E; Alluri R; Streiff MB; Petri M; Crowther MA; McCrae KR; Brodsky RA
    Blood; 2020 Jan; 135(4):239-251. PubMed ID: 31812994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.